Loading clinical trials...
Loading clinical trials...
REPRISE IV: REpositionable Percutaneous Replacement of Stenotic Aortic Valve Through Implantation of LOTUS Edge Valve System in IntermediatE Surgical Risk Subjects
Conditions
Interventions
LOTUS Edge Valve System
Locations
50
United States
Huntsville Hospital
Huntsville, Alabama, United States
Tucson Medical Center
Tucson, Arizona, United States
Arkansas Heart Hospital
Little Rock, Arkansas, United States
Mills-Peninsula Medical Center - Sutter Health
Burlingame, California, United States
Kaiser Permanente Los Angeles Medical Center
Los Angeles, California, United States
USC Medical Center
Los Angeles, California, United States
Start Date
January 14, 2019
Primary Completion Date
March 30, 2021
Completion Date
March 31, 2021
Last Updated
December 27, 2022
NCT07477002
NCT05672836
NCT05386173
NCT05930899
NCT05711186
NCT04703699
Lead Sponsor
Boston Scientific Corporation
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions